Publication date: Oct 01, 2024
Pulmonary hypertension (PH) is characterized by excessive proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), in which inflammatory signaling caused by activation of the NF-_705B pathway plays an important role. A20 is an important negative regulator of the NF-_705B pathway, and zinc promotes the expression of A20 and exerts a protective effect against various diseases (e. g. COVID19) by inhibiting the inflammatory signaling. The role of A20 and intracellular zinc signaling in PH has been explored, but the extracellular zinc signaling is not well understood, and whether zinc has protective effects on PH is still elusive. Using inductively coupled plasma mass spectrometry (ICP-MS), we studied the alteration of trace elements during the progression of monocrotaline (MCT)-induced PH and found that serum zinc concentration was decreased with the onset of PH accompanied by abnormalities of other three elements, including copper, chromium, and magnesium. Zinc chloride injection with the dosage of 5 mg/kg intraperitoneally partially corrected this abnormality and inhibited the progression of PH. Zinc supplementation induced the expression of A20 in lung tissue and reduce the inflammatory responses. In vitro, zinc supplementation time-dependently upregulated the expression of A20 in PASMCs, therefore correcting the excessive proliferation and migration of cells caused by hypoxia. Using genetically encoded-FRET based zinc probe, we found that these effects of zinc ions are not achieved by entering cells, but most likely by activating cell surface zinc receptor (ZnR/GPR39). These results provide the first evidence of the effectiveness of zinc supplementation in the treatment of PH.
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Zinc |
disease | MESH | pulmonary hypertension |
disease | IDO | role |
disease | MESH | COVID19 |
drug | DRUGBANK | Medium-chain triglycerides |
disease | MESH | abnormalities |
drug | DRUGBANK | Copper |
drug | DRUGBANK | Chromium |
drug | DRUGBANK | Magnesium |
drug | DRUGBANK | Zinc chloride |
disease | MESH | hypoxia |
pathway | REACTOME | Signal Transduction |